Amalgamated Bank’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $47K | Hold |
3,992
| – | – | ﹤0.01% | 1840 |
|
2025
Q1 | $30K | Buy |
3,992
+200
| +5% | +$1.5K | ﹤0.01% | 1936 |
|
2024
Q4 | $23K | Hold |
3,792
| – | – | ﹤0.01% | 2059 |
|
2024
Q3 | $19K | Hold |
3,792
| – | – | ﹤0.01% | 2142 |
|
2024
Q2 | $14K | Hold |
3,792
| – | – | ﹤0.01% | 2260 |
|
2024
Q1 | $12K | Sell |
3,792
-10,604
| -74% | -$33.6K | ﹤0.01% | 2339 |
|
2023
Q4 | $71K | Sell |
14,396
-1,129
| -7% | -$5.57K | ﹤0.01% | 2110 |
|
2023
Q3 | $85K | Hold |
15,525
| – | – | ﹤0.01% | 2053 |
|
2023
Q2 | $104K | Buy |
15,525
+3,883
| +33% | +$26K | ﹤0.01% | 2045 |
|
2023
Q1 | $103K | Sell |
11,642
-2,891
| -20% | -$25.6K | ﹤0.01% | 2043 |
|
2022
Q4 | $111K | Buy |
14,533
+320
| +2% | +$2.44K | ﹤0.01% | 2093 |
|
2022
Q3 | $101K | Buy |
14,213
+14
| +0.1% | +$99 | ﹤0.01% | 2140 |
|
2022
Q2 | $115K | Sell |
14,199
-10,714
| -43% | -$86.8K | ﹤0.01% | 2107 |
|
2022
Q1 | $346K | Buy |
24,913
+2,285
| +10% | +$31.7K | ﹤0.01% | 1707 |
|
2021
Q4 | $635K | Buy |
22,628
+2,944
| +15% | +$82.6K | ﹤0.01% | 1460 |
|
2021
Q3 | $669K | Sell |
19,684
-1,212
| -6% | -$41.2K | 0.01% | 1442 |
|
2021
Q2 | $854K | Buy |
20,896
+6,716
| +47% | +$274K | 0.01% | 1360 |
|
2021
Q1 | $571K | Sell |
14,180
-1,238
| -8% | -$49.9K | 0.02% | 908 |
|
2020
Q4 | $912K | Sell |
15,418
-6
| -0% | -$355 | 0.03% | 599 |
|
2020
Q3 | $750K | Buy |
15,424
+671
| +5% | +$32.6K | 0.03% | 613 |
|
2020
Q2 | $714K | Sell |
14,753
-1,558
| -10% | -$75.4K | 0.03% | 606 |
|
2020
Q1 | $453K | Buy |
+16,311
| New | +$453K | 0.01% | 956 |
|